Vericel Corp.
(NASDAQ : ASTM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-0.68%109.630.6%$525.14m
TMOThermo Fisher Scientific Inc.
0.87%297.531.0%$389.25m
ABTAbbott Laboratories
-1.12%84.260.8%$333.53m
ISRGIntuitive Surgical, Inc.
0.02%523.222.4%$312.16m
BDXBecton, Dickinson and Company
-0.57%260.671.1%$233.40m
ALGNAlign Technology, Inc.
1.63%177.476.3%$208.70m
EWEdwards Lifesciences Corporation
-0.43%219.511.2%$208.01m
BSXBoston Scientific Corporation
-0.99%41.821.1%$192.19m
SYKStryker Corporation
-0.94%217.981.3%$189.38m
BAXBaxter International Inc.
-1.05%86.901.7%$177.58m
PODDInsulet Corporation
-0.89%143.246.9%$155.20m
DXCMDexCom, Inc.
-0.61%146.268.3%$137.20m
ZBHZimmer Biomet Holdings, Inc.
-2.68%138.791.7%$126.21m
WATWaters Corporation
-0.29%232.114.0%$110.71m
COOCooper Companies, Inc.
-1.12%301.582.2%$101.20m

Company Profile

Vericel Corp. engages in the research, product development, manufacture, and distribution of patient-specific, expanded cellular therapies to repair and regenerate damaged tissues and organs to normal structure and function. Its product portfolio includes MACI and Epicel. The MACI portfolio is FDA-approved product that applies the process of tissue engineering to grow cells on scaffolds using healthy cartilage tissue from the patient's own knee. The Epicel portfolio provide skin replacement for patients who have deep dermal or full thickness burns comprising a total body surface area of greater than or equal to 30%. The company was founded on March 24, 1989 and is headquartered in Cambridge, MA.